Cite

HARVARD Citation

    Corvaja, C. et al. (2022). Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance. Expert opinion on pharmacotherapy. pp. 1765-1770. [Online]. 
  
Back to record